MyFinsight
Home
Blog
About
Net income
$17,290K
(-75.67%↓ Y/Y)
Stock-based compensation
expense
$6,844K
(3.70%↑ Y/Y)
Prepaid and other
current and non-current...
-$5,968K
(-190.58%↓ Y/Y)
Deferred income tax
$5,211K
Sale of short-term
investments
$80,933K
Accrued compensation
$2,602K
(216.06%↑ Y/Y)
Accrued research and
development
$1,190K
(2379.17%↑ Y/Y)
Depreciation and
amortization
$848K
(-29.98%↓ Y/Y)
Other accrued
liabilities
$474K
(126.29%↑ Y/Y)
Loss on
extinguishment of debt
-$209K
Right-of-use assets
$138K
(114.81%↑ Y/Y)
Maturities of short-term
investments
$11,850K
(-55.87%↓ Y/Y)
Net cash provided by
operating activities
$30,653K
(3.40%↑ Y/Y)
Net cash provided by
(used in) investing...
$17,453K
(151.59%↑ Y/Y)
Canceled cashflow
$10,121K
Canceled cashflow
$75,330K
Net increase
(decrease) in cash, cash...
$36,405K
(1209.23%↑ Y/Y)
Canceled cashflow
$11,701K
Accounts receivable, net
$6,096K
(456.91%↑ Y/Y)
Inventories
$3,259K
(-53.13%↓ Y/Y)
Accounts payable
-$475K
(-112.02%↓ Y/Y)
Lease liabilities
-$150K
(-115.86%↓ Y/Y)
Revenue reserves and
refund liability
-$106K
(-103.46%↓ Y/Y)
Net amortization of
discount on short-term...
$35K
(-92.05%↓ Y/Y)
Payments for acquisition
of intangible...
$70,347K
Purchases of short-term
investments
$4,983K
(-91.79%↓ Y/Y)
Proceeds from revolving
credit facility
$40,000K
Net proceeds from
issuance of common stock...
$1,864K
(106.65%↑ Y/Y)
Net cash (used in)
provided by financing...
-$11,701K
(-1397.23%↓ Y/Y)
Canceled cashflow
$41,864K
Repayment of term loan and
related fees
$47,750K
Closing purchase price
payment related to asset...
$5,000K
Repurchases of common stock
in connection with...
$511K
Cash paid for debt
issuance costs
$304K
Back
Back
Cash Flow
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)
source: myfinsight.com